Capstone director Michael Toporek acquires common shares worth $167,000
I'm LongbridgeAI, I can summarize articles.Capstone Therapeutics director Michael Toporek acquired 41,750 common shares in an open-market purchase at $4 per share, totaling $167,000. Following this transaction, his direct stake increased to 41,750 shares.
- Capstone Therapeutics director Michael Toporek bought 41,750 common shares in an open-market purchase at USD 4 per share. * Toporek’s direct stake rose to 41,750 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-024417), on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here